According to research reviewed by Gram, adding a formula-based Crohn’s disease diet to biologic medicine led to a bigger improvement in symptom scores in 40 children, but it did not speed up healing of the gut lining or lower stool inflammation markers.
Children with Crohn’s disease, a condition that causes long-term inflammation in the digestive tract, are often treated with biologic medicines. A new study looked at whether adding a special formula-based diet could help. According to research reviewed by Gram, kids who followed the diet alongside their medicine had a larger drop in symptom scores than kids on medicine alone. However, the diet did not speed up healing of the gut lining or lower a key stool marker of inflammation. The study was a single-hospital review of 40 children treated between 2020 and 2024. Because it looked back at medical records rather than testing the diet in a controlled trial, it cannot prove cause and effect. Still, the results suggest the diet may help with day-to-day symptoms, and larger studies are needed to confirm this.
Key Statistics
A 2026 retrospective cohort study of 40 children with Crohn’s disease found that those who added a formula-based diet to biologic medicine had a significantly greater drop in symptom scores than children on medicine alone (p = 0.029).
In the same 2026 study covering treatment from 2020 to 2024, about 72.5% of children had their stool inflammation marker, fecal calprotectin, return to normal, and 55.0% achieved mucosal healing.
The 2026 cohort study found no significant difference in healing outcomes between diet and medicine-only groups, with normal calprotectin at 4 months occurring in 23.7% of diet-group children compared with 30.8% of medicine-only children.
The Quick Take
- What they studied: Does adding a liquid, formula-based diet to standard biologic medicine help children with Crohn’s disease feel better and heal faster than medicine alone?
- Who participated: Forty children diagnosed with Crohn’s disease who started their first biologic medicine at one hospital between 2020 and 2024. About 65% were boys, and the typical age was around 12 years. Twenty-seven children chose to add the diet, and 13 took only the medicine.
- Key finding: Children who added the diet had a bigger improvement in their overall symptom score, a measure doctors use to track how sick a child feels. Other measures, such as signs of inflammation in the gut lining and in the stool, improved about the same in both groups. For example, about 72.5% of all children had their stool inflammation marker return to normal, and the difference between groups was not statistically meaningful.
- What it means for you: If your child has Crohn’s disease, the diet may help them feel better sooner, but it did not show clear extra benefits for healing inside the gut. Any change to your child’s treatment should be discussed with their gastroenterologist, who can weigh the diet’s demands against its possible benefits.
The Research Details
This was a retrospective cohort study, meaning researchers looked back at the medical records of children who had already received treatment. They compared two groups: children who started a biologic medicine and also followed a formula-based diet called the Crohn’s disease exclusion diet with partial liquid nutrition, and children who received only the biologic medicine. Children with other serious health problems, missing follow-up visits, or a switch to a different biologic medicine were left out of the review.
The researchers tracked how long it took each child to feel better and to reach key health markers. These included symptom scores, blood tests for inflammation, a stool test for gut inflammation, and a camera test that looks at the lining of the intestine. They also measured changes in weight, body size, and blood protein levels. Because the groups were not randomly assigned, the researchers used statistical methods to compare them as fairly as possible.
The choice of a real-world review makes sense for a question like this, because it reflects how the treatment is used in everyday clinical practice. It can be done faster and at lower cost than a controlled trial. However, the approach carries a higher risk that the two groups differ in ways that affect the results, so the findings are best seen as a starting point.
Crohn’s disease in children can be hard to control, and families often want to know whether diet can add to medicine rather than replace it. A real-world review shows how the approach works for typical patients in a regular hospital setting, not just in highly selected research volunteers. This helps doctors and families judge whether the diet is worth the effort. It also points to the kinds of questions that a larger, randomized study would need to answer.
The study was published in a peer-reviewed journal, which means outside experts reviewed it before publication. It used standard, widely accepted measures of Crohn’s disease activity and followed established guidelines for defining remission and healing. However, it was small, included only one hospital, and was not randomized, so the two groups may have differed in ways the researchers could not fully account for. The paper lists 65 people in its study record, but the analysis itself included 40 patients. Many of the group differences were not statistically significant, and some of the comparisons were exploratory, which means they should be viewed with caution.
What the Results Show
The main question was whether adding the diet would help children reach remission sooner. The diet group reached clinical response and clinical remission faster on average, and their blood markers of inflammation also normalized sooner. However, these differences were not large enough to rule out chance. Overall, researchers did not find a statistically clear speed advantage for the diet group on these measures.
The clearest difference appeared in the symptom score called the weighted Pediatric Crohn’s Disease Activity Index. Children in the diet group showed a significantly larger drop in this score from the start of the study, with a p-value of 0.029. In plain terms, this means the difference was unlikely to be due to chance alone. This score reflects how a child feels and functions day to day, including pain, energy, weight, and bowel habits.
For the objective measures of healing, the picture was different. About 72.5% of all children had their fecal calprotectin, a stool marker of gut inflammation, return to normal, and 55.0% achieved mucosal healing, meaning the lining of the intestine looked healed on a scope exam. The two groups did not differ in how often these outcomes occurred over time. At 4 months, 23.7% of diet-group children had normal calprotectin compared with 30.8% of medicine-only children. At 12 months, 16.0% of the diet group and 18.2% of the medicine-only group had mucosal healing.
The researchers also checked whether the location of the disease changed the results. It did not appear to. However, only 10 children had disease limited to the colon, so this part of the analysis is exploratory and should not be treated as firm guidance.
Beyond the symptom score, the researchers measured several other markers, including the Simple Endoscopic Score for Crohn’s disease, blood inflammation markers, albumin (a blood protein that reflects nutrition), and body mass index. None of these changed differently between the two groups. This suggests that, in this study, the diet did not provide extra benefit for growth, nutrition status, or measurable inflammation beyond what the medicine achieved on its own. It is worth noting that the diet involves a liquid formula that many children find demanding, and the study did not measure long-term adherence or quality of life in depth.
Previous research has shown that exclusive enteral nutrition, which means getting all or most calories from a liquid formula, can help children with Crohn’s disease reach remission. The diet studied here is a more flexible version that is combined with regular meals and biologic medicine. This study adds real-world evidence that the flexible version may help with symptoms when used alongside biologics. Its finding that healing markers did not improve further is consistent with the idea that diet and medicine may work through different pathways, with the diet mainly easing symptoms in the short term.
The study had several limitations. It was small, with only 40 children analyzed and just 13 in the medicine-only group, which makes it harder to detect real differences. It was done at a single hospital, so the results may not apply to other settings. Because it was retrospective, the researchers could not control who chose the diet, and families who chose it may have been more motivated or had different levels of support. Only 10 children had colon-only disease, limiting conclusions about disease location. The study also could not fully track how well each child followed the diet, and the follow-up periods were relatively short for judging long-term healing.
The Bottom Line
Research suggests that adding a Crohn’s disease exclusion diet with partial liquid nutrition to biologic medicine may help children feel better sooner, based on symptom scores. The evidence that it speeds up healing of the gut lining or lowers stool inflammation is weak in this study, so it should not be expected to do so. Confidence in these findings is low to moderate because the study was small and not randomized. Families should discuss the diet with their child’s care team before making changes.
Parents and caregivers of children with Crohn’s disease who are starting or taking biologic medicine may find this useful when discussing treatment options with their doctor. Dietitians and pediatric gastroenterologists who support these families may also find it helpful. Adults with Crohn’s disease, children with other digestive conditions, and people without Crohn’s disease should not apply these findings directly, since the study only looked at children with this condition who were on biologic treatment.
In this study, symptom improvements were measured over the first months of treatment, and the diet group’s symptom scores improved more over that period. Healing markers such as calprotectin and mucosal healing were measured at around 4 and 12 months, and in these areas the diet did not clearly speed up results. Families should expect that any benefit from the diet, if it occurs, would appear gradually over several months and should be checked with regular follow-up tests.
Frequently Asked Questions
Does adding a special diet to biologic medicine help kids with Crohn’s disease?
A 2026 study of 40 children found that adding a formula-based diet to biologic medicine produced a bigger improvement in symptom scores than medicine alone. The diet did not clearly speed up healing of the gut lining or reduce stool inflammation markers in this group.
Can the Crohn’s disease exclusion diet heal the gut lining faster in children?
In a study of 40 children, the diet did not show a clear advantage for healing the gut lining. About 55.0% of all children achieved mucosal healing, and the rates in the diet and medicine-only groups were similar at 12 months.
What did the research find about symptoms in children with Crohn’s disease on biologics?
Children who combined a formula-based diet with biologic medicine showed a significantly larger drop in their overall symptom score (p = 0.029). This suggests the diet may help children feel better in the short term, though larger studies are needed to confirm it.
Should parents change their child’s Crohn’s treatment based on this study?
Parents should not change treatment based on this single study alone. It was a small, non-randomized review of 40 children at one hospital. Any diet changes should be discussed with a pediatric gastroenterologist who knows the child’s full health history.
Want to Apply This Research?
- Log a daily symptom check-in that records stomach pain (0 to 10 scale), number of bowel movements, and whether blood was present. Track weekly weight and the percentage of formula consumed compared with the care plan. Review these numbers monthly with the care team.
- Set up a simple reminder schedule for formula servings and meals that matches the care plan. Use the app to record each serving so that adherence can be seen at a glance. Encourage the child to rate how they feel after each day so that patterns are easy to share at appointments.
- Over the long term, keep a running record of symptom scores, weight, growth, and results from scheduled blood and stool tests. Note the dates of any medication changes or flare-ups. Share a summary report with the care team at each visit so they can judge whether the diet is helping and decide whether to continue it.
This article summarizes a small, single-hospital retrospective study of 40 children with Crohn’s disease. It is not medical advice and does not replace care from a qualified doctor, pediatric gastroenterologist, or registered dietitian. Do not start, stop, or change any diet, formula, or biologic medicine for a child without first talking to the child’s care team. Results may differ for other children, and the study could not prove that the diet caused the observed changes.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.